Pharma Mar SA (PHMMF)
97.36
+9.78
(+11.17%)
USD |
OTCM |
Aug 27, 16:00
Pharma Mar EPS Diluted (TTM) : 3.741 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.741 |
| March 31, 2026 | 5.313 |
| December 31, 2025 | 4.974 |
| September 30, 2025 | 2.130 |
| June 30, 2025 | 2.648 |
| March 31, 2025 | 1.216 |
| December 31, 2024 | 1.594 |
| September 30, 2024 | 0.0444 |
| June 30, 2024 | -0.1067 |
| March 31, 2024 | 0.122 |
| December 31, 2023 | 0.0641 |
| September 30, 2023 | 0.8169 |
| June 30, 2023 | 1.487 |
| March 31, 2023 | 2.544 |
| December 31, 2022 | 4.882 |
| June 30, 2022 | 5.293 |
| March 31, 2022 | 5.801 |
| December 31, 2021 | 4.440 |
| September 30, 2021 | 2.424 |
| June 30, 2021 | 1.767 |
| March 31, 2021 | 3.071 |
| December 31, 2020 | 7.274 |
| September 30, 2020 | 7.802 |
| June 30, 2020 | 7.370 |
| March 31, 2020 | 4.267 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.5816 |
| September 30, 2019 | -1.707 |
| June 30, 2019 | -2.282 |
| March 31, 2019 | -1.557 |
| December 31, 2018 | -0.9991 |
| September 30, 2018 | -1.579 |
| June 30, 2018 | -1.108 |
| March 31, 2018 | -1.600 |
| December 31, 2017 | -1.654 |
| September 30, 2017 | -1.320 |
| June 30, 2017 | -1.081 |
| March 31, 2017 | -1.154 |
| December 31, 2016 | -1.437 |
| September 30, 2016 | -1.065 |
| June 30, 2016 | -0.8591 |
| March 31, 2016 | -0.4905 |
| December 31, 2015 | 0.3314 |
| September 30, 2015 | 0.0973 |
| June 30, 2015 | 0.1525 |
| March 31, 2015 | 0.1416 |
| December 31, 2014 | 0.9949 |
| September 30, 2014 | 1.131 |
| June 30, 2014 | 1.054 |
| March 31, 2014 | 1.065 |
| December 31, 2013 | -0.1855 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Oryzon Genomics SA | -0.0357 |
| Grifols SA | 0.7749 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alkermes Plc | 0.385 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |